Eli***rse

Director, Business Development

Bildung

The Wharton School

The Wharton School (2018 - 2020)

  • Degree: Master of Business Administration - MBA
  • Field of Study: Healthcare Management
  • Description: Director’s List Fellowship recipient Kaiser Family Foundation Prize recipient Kinney Scholarship recipient Kaiser Fellowship recipient

Dartmouth College (2011 - 2015)

  • Degree: Bachelor of Arts (B.A.)
  • Field of Study: Biology (Molecular Genetics), Psychology
  • Description: James O. Freedman Presidential Scholar Cum Laude Honors in Biology Thomas B. Roos Memorial Fund Fellowship

Winston Churchill High School (2007 - 2011)

  • Degree: Unknown Degree
  • Field of Study: Unknown Field
  • Description:

Fähigkeiten:

Interpersonal Communication, Due Diligence, Strategic Consulting, Oncology

Berufserfahrung:

Director, Business Development at Olema Oncology

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2023-10 to Present
  • Description:

Associate Director, Business Development at Alnylam Pharmaceuticals

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2022-07 to 2023-10
  • Description:

Senior Manager, Business Development at Alnylam Pharmaceuticals

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2020-08 to 2022-06
  • Description: - Lead/Support BD deals through all stages of the deal process from search and evaluation through agreement negotiation for all types of transactions (In and out licensing, collaboration agreements, evaluation agreements, MTAs, etc.) with a focus on transaction execution - Responsible for diligencing and prioritizing deals in close collaboration with R&D and commercial, as well as deal valuations and comps analysis

Business Development and Corporate Development Intern at Pyxis Oncology

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2020-06 to 2020-08
  • Description: - Support licensing and partnering BD deals including leading cross-functional due diligence, building business cases for deals, developing deal financial models, and incorporating business issues into term sheets - Prepared BOD and Series B pitch materials

Business Leadership Development Intern at Regeneron Pharmaceuticals, Inc.

  • Location: Tarrytown, New York
  • Duration: 2019-06 to 2019-08
  • Description: MBA Summer Associate, Oncology New Products
KI-Lebenslaufanalyse

Kandidaten-Intelligenzbericht

KI-gestützte Analyse aus der Perspektive eines US-Einstellungsdirektors — Bewertung von Karrierekontinuität, Wachstumstrajektorie und Rollenpassung.

Karrierekontinuität und Risikobewertung

Employment GapLow

No material employment gap; the brief 2019–2020 transition is explained by MBA-related internships and program timing, followed by continuous BD-focused roles in oncology.

Industry ConsistencyLow

Career is concentrated in oncology BD across multiple biotech companies, showing strong industry alignment and domain expertise with increasing deal-execution responsibilities.

Tenure StabilityLow

Progression from Senior Manager to Associate Director to Director within a clear succession path at compatible firms demonstrates stability and growth, including a multi-year tenure at Alnylam before moving to Olema.

Education-Career MatchLow

Wharton education aligns well with advanced BD leadership in biopharma, complemented by hands-on deal origination, diligence, and financial modeling experience.

Karrierewachstumskurve

Business Leadership Development Intern Entry
Regeneron Pharmaceuticals, Inc.
2019-06 to 2019-08
Business Development and Corporate Development Intern Entry
Pyxis Oncology
2020-06 to 2020-08
Senior Manager, Business Development ↑ Befördert
Alnylam Pharmaceuticals
2020-08 to 2022-06
Associate Director, Business Development ↑ Befördert
Alnylam Pharmaceuticals
2022-07 to 2023-10
Director, Business Development ↑ Befördert
Olema Oncology
2023-10 to Present
Bewertung:Elizabeth Morse presents a consistent upward trajectory within oncology BD, with progressive responsibilities in deal sourcing, diligence, valuation, and cross-functional leadership. With an MBA from Wharton and a solid track record at Alnylam and Olema, she is well-positioned for senior leadership (VP/Head of BD) in oncology-focused biopharma or biotech.

Bestpassende Rollen (Top 5)

1

Vice President, Business Development – Oncology96% Passung

Direct progression from Director in oncology BD, plus MBA credentials and proven record of end-to-end deal leadership across licensing, partnerships, and collaborations; ready to lead a BD function and strategy at scale.

2

Head of Business Development – Oncology92% Passung

Strategic leadership across pipeline prioritization, cross-functional alignment, and negotiations; strong track record in deal execution makes she a strong candidate to own the BD strategy for a growth-stage or mid-cap biotech.

3

Senior Director, Corporate Development – Oncology89% Passung

Advanced BD leadership with experience managing complex transactions and valuations; suitable for larger teams and broader portfolio oversight in a larger organization.

4

Director, Strategic Partnerships – Biotech/Pharma82% Passung

Strong alignment with alliance management and cross-functional deal execution; good fit for organizations seeking to optimize external collaborations and co-development deals.

5

Director, Licensing & Partnerships – Oncology78% Passung

Specialized licensing/partnerships focus aligns with prior BD experience; suitable for roles emphasizing licensing strategy and deal structuring within oncology.

Erleben Sie AI Recruiter

Kostenlos starten. Lassen Sie Ihre Konkurrenten nicht den KI-Vorteil zuerst ergattern.

Schließen Sie sich über 10.000 Unternehmen an, die KI-gestützte Recruiting-Lösungen nutzen, um Ihren Einstellungsprozess zu automatisieren und 80% Zeitkosten zu sparen.

33% Rabatt, nur noch 48 Stunden!
Kostenlos AI testen

24/7 automatisierter Betrieb

KI-gestützte Kandidatenauswahl

Recruiting ohne geografische oder zeitliche Einschränkungen

Personalisierte intelligente Kommunikation

Automatisierte Bewertung des Kandidatenengagements

Ahmt Ihren Recruiting-Stil intelligent nach

4-monatige Geld-zurück-Garantie

Gewährleistet LinkedIn-Kontosicherheit